Biomarker-guided antibiotic therapy-strengths and limitations
about
The usefulness of appetite and energy intake-based algorithms to assess treatment effect of a bacterial infection: An observational prospective study.The social role of C-reactive protein point-of-care testing to guide antibiotic prescription in Northern Thailand.Feasibility of Antimicrobial Stewardship (AMS) in Critical Care Settings: A Multidisciplinary Approach Strategy.Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia.
P2860
Biomarker-guided antibiotic therapy-strengths and limitations
description
2017 nî lūn-bûn
@nan
2017 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Biomarker-guided antibiotic therapy-strengths and limitations
@ast
Biomarker-guided antibiotic therapy-strengths and limitations
@en
type
label
Biomarker-guided antibiotic therapy-strengths and limitations
@ast
Biomarker-guided antibiotic therapy-strengths and limitations
@en
prefLabel
Biomarker-guided antibiotic therapy-strengths and limitations
@ast
Biomarker-guided antibiotic therapy-strengths and limitations
@en
P2093
P2860
P356
P1476
Biomarker-guided antibiotic therapy-strengths and limitations
@en
P2093
David Nora
Ignacio Martin-Loeches
Jorge Salluh
Pedro Póvoa
P2860
P356
10.21037/ATM.2017.04.04
P577
2017-05-01T00:00:00Z